 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              The equity shares of Parabolic Drugs Ltd (BSE Scrip Code: 533211) was listed and admitted to dealings on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) from July 1, 2010.
The stock opened in BSE for the day at Rs 76, up by Rs.1 as compared to the IPO price of Rs 75 per share.
The stock was last trading in BSE at Rs.67.40, down by Rs.7.60 or 10.13%. The stock hit an intraday high of Rs.79 and low of Rs.65.30.
The total traded quantity was 5379841 at a weighted average price of Rs 69.01.